Large increase in cardiac output in a patient with ARDS and acute right heart failure during inhalation of nitric oxide.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 9181169.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Inhaled nitric oxide (NO), a selective pulmonary vasodilator, reduces pulmonary artery pressure in patients with acute respiratory distress syndrome (ARDS). In spite of the reduction of right ventricular afterload, the effect of NO on cardiac output remains unclear. A patient with ARDS and echocardiographically determined severe acute right heart failure was treated with increasing concentrations of inhaled nitric oxide (NO). Haemodynamic and gas exchange variables were determined for each concentration of NO. NO treatment was continued for 3 days. During initial right heart failure, administration of NO resulted in a large increase (32%) in cardiac output in a dose-dependent manner. When right ventricular function had improved, inhalation of NO did not increase cardiac output. Our observations suggest that inhalation of NO is likely to increase cardiac output in ARDS when severe acute right heart failure is present.
Medical subject headings
- Cardiac Output
- Heart Failure
- Nitric Oxide
- Respiratory Distress Syndrome
- Vasodilator Agents
- Ventricular Dysfunction, Right